GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai InnoStar Bio-tech Co Ltd (SHSE:688710) » Definitions » Change In Receivables

Shanghai InnoStar Bio-tech Co (SHSE:688710) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Shanghai InnoStar Bio-tech Co Change In Receivables?

Shanghai InnoStar Bio-tech Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Shanghai InnoStar Bio-tech Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Shanghai InnoStar Bio-tech Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥23 Mil. It means Shanghai InnoStar Bio-tech Co's Accounts Receivable declined by ¥23 Mil from Dec. 2023 to Dec. 2024 .

Shanghai InnoStar Bio-tech Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥299 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai InnoStar Bio-tech Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 130.61.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai InnoStar Bio-tech Co's liquidation value for the three months ended in Mar. 2025 was ¥876 Mil.


Shanghai InnoStar Bio-tech Co Change In Receivables Historical Data

The historical data trend for Shanghai InnoStar Bio-tech Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai InnoStar Bio-tech Co Change In Receivables Chart

Shanghai InnoStar Bio-tech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial -55.03 -51.82 -61.37 -49.25 23.44

Shanghai InnoStar Bio-tech Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai InnoStar Bio-tech Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai InnoStar Bio-tech Co  (SHSE:688710) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai InnoStar Bio-tech Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=299.401/209.174*91
=130.61

2. In Ben Graham's calculation of liquidation value, Shanghai InnoStar Bio-tech Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai InnoStar Bio-tech Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1314.529-827.611+0.75 * 299.401+0.5 * 328.526
=876

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai InnoStar Bio-tech Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai InnoStar Bio-tech Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai InnoStar Bio-tech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 199 Guo Shoujing Road, Room 106, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.

Shanghai InnoStar Bio-tech Co Headlines

No Headlines